Phenomenex Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
DESCRIPTION
TABLE OF CONTENTS
RELATED REPORTS
SAMPLE REQUEST
REVIEWS
DESCRIPTION
Summary
Phenomenex Inc (Phenomenex) is a technology service provider that develops analytical chemistry solutions. The companys products include amino acid analysis, gas chromatography, HPLC and UHPLC, preparative columns, bulk media, SFC, oligonucleotides and accessories. Its accessories include vials, syringe filters, column protection HPLC accessories, GC inlet liners and accessories, and SPE accessories. Phenomenex serves clinical research, environmental, food and beverage, toxicology, chemicals and energy, pharamaceutical and biopharmaceutical sectors. The company offers technical support, troubleshooting, training and on-site support, method development services, and chiral screening service. It has operations in India, Australia, Austria, Canada, Denmark, Belgium, Finland, Italy, the Netherlands, Mexico, the UK, and others. Phenomenex is headquartered in Torrance, California, the US.
Phenomenex Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Phenomenex Inc (Phenomenex) is a technology service provider that develops analytical chemistry solutions. The companys products include amino acid analysis, gas chromatography, HPLC and UHPLC, preparative columns, bulk media, SFC, oligonucleotides and accessories. Its accessories include vials, syringe filters, column protection HPLC accessories, GC inlet liners and accessories, and SPE accessories. Phenomenex serves clinical research, environmental, food and beverage, toxicology, chemicals and energy, pharamaceutical and biopharmaceutical sectors. The company offers technical support, troubleshooting, training and on-site support, method development services, and chiral screening service. It has operations in India, Australia, Austria, Canada, Denmark, Belgium, Finland, Italy, the Netherlands, Mexico, the UK, and others. Phenomenex is headquartered in Torrance, California, the US.
Phenomenex Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.
Scope
- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.
Reasons to Buy
Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.
Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.
Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.
Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
TABLE OF CONTENTS
Phenomenex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Phenomenex Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Phenomenex Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Phenomenex Inc, Medical Devices Deals, 2011 to YTD 2017 8
Phenomenex Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Phenomenex Inc, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Phenomenex Enters Into Co-Marketing Agreement With Shimadzu Scientific 10
Acquisition 11
Danaher to Acquire Phenomenex 11
Alastair John Gray Sells Stake In Phenomenex To Farajollah Farshad Mahjoor 12
Phenomenex Inc - Key Competitors 13
Phenomenex Inc - Key Employees 14
Phenomenex Inc - Locations And Subsidiaries 15
Head Office 15
Other Locations & Subsidiaries 15
Recent Developments 17
Product News 17
Nov 30, 2016: New Clarity Columns Refine RP and IEX Chromatographic Analysis of Synthetic Oligonucleotides 17
Oct 25, 2016: Phenomenex Adds Polar Mixed-Mode Selectivities to Luna LC Column Line 18
Aug 23, 2016: Phenomenex: Yarra 1.8m UHPLC Size Exclusion Column Delivers Increased Separation of High Molecular Weight Biomolecules 19
Jun 12, 2017: New Immobilized Lux Chiral LC-SFC Selector from Phenomenex Delivers Broad Enantioselectivity 20
May 18, 2017: New 3 m Particle Size Adds HPLC Scalability to Luna Omega Mixed-Mode Selectivities 21
Mar 16, 2016: New Luna Omega 1.6 Micron Particle Brings Acclaimed Capabilities to UHPLC 22
Feb 09, 2016: Phenomenex Expands Chiral Screening and Separation Power with New Lux 3m Amylose-1 Chiral Columns 23
Other Significant Developments 24
Sep 05, 2017: Phenomenex Announces Direct Sales and Support in Switzerland 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25
List Of Tables
Phenomenex Inc, Pharmaceuticals & Healthcare, Key Facts 2
Phenomenex Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 2
Phenomenex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Phenomenex Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Phenomenex Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Phenomenex Inc, Medical Devices Deals, 2011 to YTD 2017 8
Phenomenex Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Phenomenex Enters Into Co-Marketing Agreement With Shimadzu Scientific 10
Danaher to Acquire Phenomenex 11
Alastair John Gray Sells Stake In Phenomenex To Farajollah Farshad Mahjoor 12
Phenomenex Inc, Key Competitors 13
Phenomenex Inc, Key Employees 14
Phenomenex Inc, Other Locations 15
Phenomenex Inc, Subsidiaries 16
List Of Figures
Phenomenex Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
Phenomenex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
Phenomenex Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
Phenomenex Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Phenomenex Inc, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Phenomenex Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Phenomenex Inc, Medical Devices Deals, 2011 to YTD 2017 8
RELATED REPORTS
Binx Health Inc - Product Pipeline Analysis, 2021 Update
Binx Health Inc (Binx Health), a subsidiary of Binx Health Ltd, is a provider of near-patient and point of care (POC) testing solutions for womens health. The company develops its
View ReportProfound Medical Inc - Product Pipeline Analysis, 2021 Update
Profound Medical Inc (Profound Medical) is a medical device company that develops and markets solutions to deliver precise ablation of prostate. Its proprietary technology, TULSA-PRO, by combining real-time magnetic resonance
View ReportSAMPLE REQUEST
Fill The Form For Sample Request
REVIEWS
